Quantcast
Last updated on May 29, 2012 at 13:25 EDT

Fougera Extends Line With Introduction of Clotrimazole & Betamethasone Dipropionate Lotion USP 1%/0.05% (Base) (Rx).

July 13, 2005
Repost This

MELVILLE, N.Y., July 13 /PRNewswire/ — Today, the specialty pharmaceutical manufacturer Fougera released FDA approved Clotrimazole & Betamethasone Dipropionate Lotion USP 1%/0.05% (Rx). This combination product is AB rated to Lotrisone(R) by Schering(R) and is available in 30 ml bottles.

(Photo: http://www.newscom.com/cgi-bin/prnh/20050713/NYW125 )

David Klaum, Vice President of Sales and Marketing, stated, “With Clotrimazole & Betamethasone Dipropionate Lotion joining Fougera’s Clotrimazole & Betamethasone Dipropionate Cream, we have expanded this important product line, thereby increasing the prescription choices for both health care professionals and their patients. This is another example of Fougera’s ability to deliver cost-effective choices to the marketplace that are both efficacious and safe.”

As a specialty pharmaceutical manufacturer of topical steroids, antibiotics and antifungal products, as well as ophthalmics, Fougera has received more topical generic FDA approvals than any other company during the past six years. This ability to provide a continuing stream of new products benefits both health care providers seeking multi-source alternatives with the ability to reduce health care costs, and patients whose conditions warrant their application.

For more information on Fougera’s complete line of topicals, or any other quality Fougera product, please call Fougera Customer Service at (800) 645-9833. Or visit the company online at http://www.fougera.com/.

Fougera is a leading manufacturer and distributor of a wide range of multi-source topical and ophthalmic pharmaceuticals, in both prescription and over-the-counter dosage forms.

Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20050713/NYW125AP Archive: http://photoarchive.ap.org/AP PhotoExpress Network: PRN7PRN Photo Desk, photodesk@prnewswire.com

Fougera

CONTACT: Nicole Smith, HLD/Blankman Public Relations, +1-516-536-6811,nsmith@hldblankman.com

Web site: http://www.fougera.com/